Evidence map›Paper›PMID 40998819›Full record

ArticleNature communications2025

MRAP2 modifies the signaling and oligomerization state of the melanocortin-4 receptor.

Iqra Sohail, Suli-Anne Laurin, Gunnar Kleinau, Vidicha Chunilal, Andrew Morton, Alfonso Brenlla, Zeynep Cansu Uretmen Kagiali, Marie-José Blouin, Javier A Tello, Annette G Beck-Sickinger and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Iqra Sohail *Max-Delbrück-Center for Molecular Medicine-Berlin, Berlin, Germany.ORCID http://orcid.org/0009-0007-1828-4098
Suli-Anne Laurin *Institute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada.ORCID http://orcid.org/0000-0001-6713-4503
Gunnar KleinauCharité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Physics and Biophysics, Group Structural Biology of Cellular Signaling, Berlin, Germany.
Vidicha ChunilalCentre for Endocrinology, William Harvey Research Institute Queen Mary University of London, London, UK.
Andrew MortonSchool of Physics and Astronomy, University of St Andrews, St Andrews, UK.
Alfonso BrenllaSchool of Physics and Astronomy, University of St Andrews, St Andrews, UK.
Zeynep Cansu Uretmen KagialiCharité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute for Experimental Paediatric Endocrinology, Berlin, Germany.ORCID http://orcid.org/0000-0003-0007-5814
Marie-José BlouinInstitute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada.ORCID http://orcid.org/0009-0003-8032-2789
Javier A TelloSchool of Medicine, University of St Andrews, St Andrews, UK.ORCID http://orcid.org/0000-0001-6637-2155
Annette G Beck-SickingerFaculty of Life Sciences, Institute of Biochemistry, University of Leipzig, Leipzig, Germany.ORCID http://orcid.org/0000-0003-4560-8020
Martin J LohseMax-Delbrück-Center for Molecular Medicine-Berlin, Berlin, Germany.
Patrick ScheererCharité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Physics and Biophysics, Group Structural Biology of Cellular Signaling, Berlin, Germany.ORCID http://orcid.org/0000-0001-5028-2075
Michel BouvierInstitute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada. michel.bouvier@umontreal.ca.ORCID http://orcid.org/0000-0003-1128-0100
Peter McCormickDepartment of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK. peter.mccormick@liverpool.ac.uk.ORCID http://orcid.org/0000-0002-2225-5181
Paolo AnnibaleMax-Delbrück-Center for Molecular Medicine-Berlin, Berlin, Germany. pa53@st-andrews.ac.uk.ORCID http://orcid.org/0000-0003-3208-5347
Heike BiebermannCharité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute for Experimental Paediatric Endocrinology, Berlin, Germany. heike.biebermann@charite.de.ORCID http://orcid.org/0000-0002-2024-7778

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 421152132EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 956314Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (Skin Research Training Centre) PJT-183758Leverhulme Trust RL-2022-015
6 · The paper itself

Abstract

The melanocortin-4 receptor is a G protein-coupled receptor and a key regulator of appetite and metabolism. It can interact with the melanocortin-receptor accessory protein 2, a single transmembrane helix protein known to interact with several different G protein-coupled receptors. However, the consequences of this interaction are not completely understood. Here we report that co-expression of melanocortin-receptor accessory protein 2 has multiple effects on the melanocortin-4 receptor: it enhances G protein-mediated signaling and simultaneously impairs β-arrestin2 recruitment and, consequently, internalization. In addition, co-expression of melanocortin-receptor accessory protein 2 leads to an increased number of monomers of melanocortin-4 receptor by disrupting receptor oligomers. A structural homology model of the active state melanocortin-4 receptor - melanocortin-receptor accessory protein 2 - Gα

Indexed as

Membrane ProteinsReceptor, Melanocortin, Type 4Signal TransductionAdaptor Proteins, Signal TransducingAnimalsbeta-Arrestin 2HEK293 CellsHumansModels, MolecularProtein BindingProtein MultimerizationAdaptor Proteins, Signal Transducingbeta-Arrestin 2MC4R protein, humanMembrane ProteinsMRAP2 protein, humanReceptor, Melanocortin, Type 4

Identifiers

PMID40998819
PMCPMC12462500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.